"Arthritis, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
ARTHRITIS that is induced in experimental animals. Immunological methods and infectious agents can be used to develop experimental arthritis models. These methods include injections of stimulators of the immune response, such as an adjuvant (ADJUVANTS, IMMUNOLOGIC) or COLLAGEN.
| Descriptor ID |
D001169
|
| MeSH Number(s) |
C05.550.114.015 E05.598.500.249
|
| Concept/Terms |
Arthritis, Collagen-Induced- Arthritis, Collagen-Induced
- Collagen-Induced Arthritides
- Collagen-Induced Arthritis
- Collagen Arthritis
- Arthritides, Collagen
- Arthritis, Collagen
- Collagen Arthritides
|
Below are MeSH descriptors whose meaning is more general than "Arthritis, Experimental".
Below are MeSH descriptors whose meaning is more specific than "Arthritis, Experimental".
This graph shows the total number of publications written about "Arthritis, Experimental" by people in this website by year, and whether "Arthritis, Experimental" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 5 | 2 | 7 |
| 2018 | 6 | 3 | 9 |
| 2019 | 4 | 1 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Arthritis, Experimental" by people in Profiles.
-
PdCl2-catalyzed synthesis of a new class of isocoumarin derivatives containing aminosulfonyl / aminocarboxamide moiety: First identification of a isocoumarin based PDE4 inhibitor. Eur J Med Chem. 2021 Oct 05; 221:113514.
-
Ca2+ signalling plays a role in celastrol-mediated suppression of synovial fibroblasts of rheumatoid arthritis patients and experimental arthritis in rats. Br J Pharmacol. 2019 08; 176(16):2922-2944.
-
Soluble CD83 Triggers Resolution of Arthritis and Sustained Inflammation Control in IDO Dependent Manner. Front Immunol. 2019; 10:633.
-
Design, synthesis and evaluation of novel 7H-pyrrolo[2,3-d]pyrimidin-4-amine derivatives as potent, selective and reversible Bruton's tyrosine kinase (BTK) inhibitors for the treatment of rheumatoid arthritis. Eur J Med Chem. 2019 May 01; 169:121-143.
-
Effect of Chondroitin Sulfate on Blood Serum Cytokine Profile during Carrageenan-induced Edema and Monoiodoacetate-induced Osteoarthritis in Rats. Rev Recent Clin Trials. 2019; 14(1):50-55.
-
In Vivo Models of Rheumatoid Arthritis. Methods Mol Biol. 2019; 1914:269-280.
-
Therapeutic Potential of Mesenchymal Cell-Derived miRNA-150-5p-Expressing Exosomes in Rheumatoid Arthritis Mediated by the Modulation of MMP14 and VEGF. J Immunol. 2018 10 15; 201(8):2472-2482.
-
Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat Nanotechnol. 2018 12; 13(12):1182-1190.
-
Helminths-based bi-functional molecule, tuftsin-phosphorylcholine (TPC), ameliorates an established murine arthritis. PLoS One. 2018; 13(8):e0200615.
-
NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis. Arthritis Res Ther. 2018 08 03; 20(1):169.